Since the activation of MC5R stimulates the proliferation of MDSCs from the bone niche, the human cohorts with natural loss of function of MC5R may have decreased incidence of all types of cancers with low plasma level of circulating MDSCs. The gene discussed is MC5R; the disease is cancer.